Through a blend of polymer science and capsule engineering, Capsugel has developed a line of functional capsules that provides the industry with a viable alternative to achieve enteric protection and delayed release without functional (enteric) coating.
Through a blend of polymer science and capsule engineering, Capsugel has developed a line of functional capsules that provides the industry with a viable alternative to achieve enteric protection and delayed release without functional (enteric) coating.
Intrinsically enteric capsule technologies are key product design and development tools within the Capsugel targeted delivery technology suite, and can be coupled with a range of additional enabling technologies to meet the bioavailability and pharmacokinetic profile required for your drug product.
Vcaps Enteric Capsules is a capsule technology that simplifies drug enteric delivery implementation from early-stage development to commercial manufacturing. The pharmaceutical grades of cellulosic derivatives used in Vcaps Enteric capsules have extensive market precedence for use in providing enteric protection.
Vcaps Enteric capsules have been evaluated in-vitro and in-vivo across a number of compounds, which has proven full compliance with relevant European, Japanese and US pharmacopoeia monographs.
Vcaps Enteric Capsules have a number of potential applications in terms of functionality, use in product development tools, and as branding and intellectual property considerations.
Proven functionality
A unique technology
As a proprietary technology, and a viable alternative to enteric coating in the pharmaceutical industry, our intrinsically enteric capsule technologies offer potential product differentiation, lifecycle management, and intellectual property opportunities.
Tool for rapid product development
Vcaps Enteric capsules can be utilised to greatly simplify and accelerate prototype development and rapid in-vivo testing of products requiring targeted delivery to the upper GI tract:
By removing the need for enteric coating, intrinsically enteric capsule technologies also offer tremendous potential in early-stage product development, and can be utilised to greatly simplify formulation and process development, as well as scale-up and validation. Independent analysis has indicated that more than nine months of savings in Phase III readiness may be achievable by eliminating development, scale-up and validation steps associated with an enteric coating.
Key product details:
Click here for more information.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
